Home
About
Leadership
Medical Advisory Board (AC5)
Scientific & Clinical Advisors
Corporate Mission
Products
Ordering Information
Intellectual Property
AC5 Advanced Wound System
Technology
Platform
Preclinical Data
Clinical Data
Pipeline
Pipeline Opportunity
Investors
Investor Relations
IR Overview
News
Press Releases
IR Calendar
Presentations
Other News
Stock Data
Quote
Charts
Historical Data
Analyst Coverage
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Corporate Governance
Governance Documents
Contact
Home
Investors
News
Press Releases
Investors
Overview
News
Press Releases
IR Calendar
Presentations
Other News
Stock Data
SEC Filings
Corporate Governance
Press Releases
All News
By Year:
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
10/1/24
Arch Therapeutics to Present AC5® Advanced Wound System at the 2024 Symposium on Advanced Wound Care Fall Meeting (SAWC Fall)
05/6/24
Arch Therapeutics to Present AC5® Advanced Wound System at the 2024 Symposium on Advanced Wound Care Spring Meeting (SAWC Spring)
11/9/23
Arch Therapeutics Provides Year End Operational Update
11/2/23
Arch Therapeutics to Present AC5® Advanced Wound System at the 2023 Symposium on Advanced Wound Care Fall Meeting (SAWC Fall)
09/13/23
Arch Therapeutics Provides AC5® Commercialization Update
09/7/23
Arch Therapeutics Completes Financing as Bridge to Uplisting
04/25/23
Arch Therapeutics to Present AC5® Advanced Wound System at 2023 Symposium on Advanced Wound Care (“SAWC”)
04/5/23
Dedicated HCPCS Billing Code for Arch Therapeutics’ AC5® Advanced Wound System Now In Effect
03/9/23
Arch Therapeutics’ AC5® Advanced Wound System Receives Dedicated HCPCS Billing Code from The Centers for Medicare & Medicaid Services
03/7/23
Arch Therapeutics Announces Addition of Contract Sales Force to Advance Commercialization of AC5® Advanced Wound System in Government Facilities
1
2
3
4
5
6
7
8
9
10
...14
Next >>
Show All